Stan Honda / AFP/Getty Images
November 20, 2012
U.S. Atty. Preet Bharara in New York announces insider-trading charges against former hedge fund manager Mathew Martoma for an alleged scheme to profit from clinical trial results for an Alzheimer's disease drug.
Comments are filtered for language and registration is required. The Times makes no guarantee of comments' factual accuracy. Readers may report inappropriate comments by clicking the Report Abuse link next to a comment. Here are the full legal terms you agree to by using this comment form.